Cromos Pharma on clinical trial trends for 2022 2021 was a year of recalibration for the clinical trials industry as it began to recover from the impact of the COVID-19 pandemic. Although challenges remain with the emergence of new waves and variants, the adaptions the industry made during the peak of the pandemic have had a positive impact allowing the drug trials sector to rebound. What
Connect with Cromos Pharma at the 40th JP Morgan Healthcare Conference The JP Morgan Healthcare Conference is recognized as one of the largest and most anticipated life science industry events. In this article Cromos Pharma’s CEO Vlad Bogin gives his take on the importance of participating in this week. You been attending for over 10 years – what has your experience been of the event thus far? I cannot think
Cromos Pharma supporting clinical trials to advance HIV treatments World AIDS Day, observed every year on December 1st, is an international day dedicated to raising awareness of HIV/AIDS, remembering those who have died, and showing support for the millions living with HIV/AIDS. HIV/AIDS Global Statistics[i] 2021 marks the 33rd year of World AIDS Day which was first established by the UN in 1988. It also marks
